Adlyxin regulatory update

FDA approved an NDA from Sanofi for Adlyxin lixisenatide as an adjunct to diet and exercise to treat Type II diabetes. The once-daily glucagon-like peptide-1 receptor ( GLP-1R; GLP1R) agonist is mar...